19
1 4/8/2016 Copyright by Dr. TC Theoharides 1 Theoharis C. Theoharides, MS, MPhil, PhD, MD, FAAAAI Professor of Pharmacology, Internal Medicine and Psychiatry Director, Molecular Immunopharmacology and Drug Discovery Tufts University School Medicine, Boston, MA, USA [email protected] www.mastcellmaster.com www.autismfreebrain.org www.brain-gate.org 1 4/8/2016 Copyright by Dr. TC Theoharides An Autism Subgroup With Brain Inflammation Is Treatable Disclosures Scientific Director and shareholder of Algonot, LLC Medical Advisory Board, The Mastocytosis Society 4/8/2016 Copyright by Dr. TC Theoharides 2 Autism Spectrum Disorders Rett Syndrome Autistic Disorder Childhood Disintegrative Disorder PDD-NOS* Asperger’s Syndrome PDDNOS, pervasive developmental disorder not otherwise specified. ADD/ADHD Allergies/Food intolerance Gastrointestinal problems Mitochondrial dysfunction PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections) PTEN mutations (large skull, headaches) Seizures Subgroups K. Weintraub, Nature 479, Nov. 3 2011, 22-24. Deficits in communication and sociability together with repetitive movements Now 1 in 45 children

An Autism Subgroup With Brain Inflammation Is … Theoharides 052816.pdfTitle: Microsoft PowerPoint - An Autism Subgroup With Brain Inflammation Is Treatable, Gen Session AutismOne

  • Upload
    lydiep

  • View
    216

  • Download
    2

Embed Size (px)

Citation preview

1

4/8/2016 Copyright by Dr. TC Theoharides 1

Theoharis C. Theoharides, MS, MPhil, PhD, MD, FAAAAI

Professor of Pharmacology, Internal Medicine and Psychiatry

Director, Molecular Immunopharmacology and Drug DiscoveryTufts University School Medicine, Boston, MA, USA

drtheoharides@gmail.comwww.mastcellmaster.comwww.autismfreebrain.org

www.brain-gate.org

14/8/2016 Copyright by Dr. TC Theoharides

An Autism Subgroup With Brain Inflammation

Is Treatable

Disclosures

• Scientific Director and shareholder of Algonot, LLC

• Medical Advisory Board, The Mastocytosis Society

4/8/2016 Copyright by Dr. TC Theoharides 2

Autism Spectrum Disorders

Rett Syndrome

Autistic Disorder

Childhood Disintegrative

Disorder

PDD-NOS* Asperger’s SyndromePDD‐NOS, pervasive 

developmental  disorder not otherwise specified.

• ADD/ADHD• Allergies/Food intolerance• Gastrointestinal problems• Mitochondrial dysfunction• PANDAS (Pediatric Autoimmune Neuropsychiatric

Disorders Associated With Streptococcal Infections)• PTEN mutations (large skull, headaches)• Seizures

Subgroups

K. Weintraub, Nature 479, Nov. 3 2011, 22-24.

Deficits in communication and sociability together with repetitive movements

Now 1 in 45 children

2

4/8/2016 Copyright by Dr. TC Theoharides 4

Presenting Behavior Suggestive of Autism

• No response when calling name• Isolation• No group play• Loss of vocabulary• Rigid routines• Lack of imaginative play• Inability to follow directions• Anxiety• Intolerance to stress• Repetitive non-purposeful

movements• Hyperactivity• Tantrums• Tip-toeing• Hand flapping• Intolerance to sensory overload• Strange food habits

4/8/2016 5Copyright by Dr. TC Theoharides

Gestational and Perinatal Factors Increasing Autism Risk

Gestational

• Allergies/Asthma• Autoimmune diseases• Diabetes• Infection• Low Vitamin D• Pre-eclampsia• Psoriasis• Psychotropic drug use • Stress

Perinatal• Excessive oxytocin to induce labor

• High fever

• Incubation/maternal separation stress

• Infection

• Low birth weight

• Perinatal anoxia

• Preterm birth

3

Diencephalon(coordinates sensory input and emotions)

Mast Cell Activation

Dysfunctional social behavior, communication and stereotypic

movements

4/8/2016 Copyright by Dr. TC Theo harides 7

There was significant association with food intolerance (P = 0.001).

9Copyright Dr. T.C. Theoharides4/8/2016

4

4/8/2016 Copyright by Dr. TC Theoharides 10

Croen et al. Arch Pediatr Adolesc Med 2005;159:151-7.

4/8/2016 Copyright by Dr. TC Theoharides 11

4/8/2016 Copyright by Dr. TC Theoharides 12

Autism Spectrum Disorders and MastocytosisTheoharides TC. Int J Immunopathol Pharmacol.

2009 Oct-Dec;22(4):859-65.The risk of autism was 10 times higher than in the general population.

5

4/8/2016 Copyright by Dr. TC Theoharides 13

4/8/201614

Copyright by Dr. TC Theoharides

4/8/2016 15Copyright by Dr. TC Theoharides

6

4/8/2016 Copyright by Dr. TC Theoharides 164/8/2016 16Copyright by Dr. TC Theoharides

4/8/2016 Copyright by Dr. TC Theoharides 17

Is There Evidence of Inflammation in the Brain?

• Activation and proliferation of microglia, the brain immune cells, causes local inflammation and “choking” of neuronal connectivity

4/8/2016 Copyright by Dr. TC Theoharides 18

7

4/8/2016 19Copyright by Dr. TC Theoharides

4/8/2016 Copyright by Dr. TC Theoharides 20

IL-6, TNFMicroglia

Neuron

Mast cell

8

How Can Stress Contribute to Inflammation of the Brain?

• Disrupts the gut-blood barrier

• Opens up the blood-brain barrier

• Stimulates mast cells

• Triggers microglia cells

4/8/2016 Copyright by Dr. TC Theoharides 22

4/8/2016 23Copyright by Dr. TC Theoharides

Prenatal Stress Has Been Associated With High Risk of Developing Autism

9

tv 99Tc-G

30 minutes restraint stress

C57BL +/+ normalW/Wv mast cell-deficient

mouse

4/8/2016 25Copyright Dr. T.C. Theoharides

0

50

100

150

200

*

+/+ W/Wv%

ch

ang

e fr

om

co

ntr

ol

4/8/2016 Copyright by Dr. TC Theoharides 26

Intradermal CRH Injection Induces Skin Vascular Permeability, but not in W/Wv Mast Cell Deficient Mice

4/8/2016 Copyright by Dr. TC Theoharides 27

Culture of human umbilical cord blood-derived mast cells (hCBMCs)

Culture with SCF (100 ng/ml) and IL-6 (50 ng/ml) for 8-16 wk yields 100% tryptase-positive mast cells

CD34+ cells

mast cellsKempuraj D., Saito H. et al. Blood 93: 3338-3346, 1999.

RBCs

MNCs

AC133 mAb

MACs

10

4/8/2016 Copyright by Dr. TC Theoharides 28

Immunocytochemistry of CRH-R in human mast cells

F G

B

-

R1 no IL-4

DCA E

E F

B

R1 + IL-4

A B

R2 no IL-4 R2 + IL-4

DB

No R1 primary DAPI

4/8/2016 28

4/8/2016 Copyright by Dr. TC Theoharides 29

Effect of Mast Cells on the HPA Axis

4/8/2016 Copyright by Dr. TC Theoharides 30

11

The Peptide Neurotensin Can Trigger Inflammation of the Brain

• Is increased in the blood of children with ASD

• Is found in the brain and gut

• Stimulates mast cells and microglia

• Has synergistic action with CRH

• Opens up the blood-brain barrier

• Is neurotoxic

4/8/2016 Copyright by Dr. TC Theoharides 31

What Triggers Inflammation in the Brain?

4/8/2016 Copyright by Dr. TC Theoharides 33

12

4/8/2016 Copyright by Dr. TC Theoharides 344/8/2016 34

01020304050

control 1nM 10nM 100nM 1uMCRH

VE

GF

A) B)

C) D)

Figure 3 Microglia Express NTR3/Sortilin, which is Elevated in the Serum of Children with ASD

4/8/2016 Copyright by Dr. TC Theoharides 36

Neurotensin Stimulates Human Microglia IL1 Gene Expression and Release

13

4/8/2016 Copyright by Dr. TC Theoharides 37

4/8/2016 Copyright by Dr. TC Theoharides 38

Treatment

Beaudet. Science; 338:342-3, 2012

14

Wong AY et al., Autism Res. 2014 Oct;7(5):543-54

Most Countries Use Psychotropic Drugs in Children with ASDs

Luteolin (3′,4′,5,7-tetrahydroxyflavone)

Methoxyluteolin (3′,4′,5,7-tetramethoxyluteolin)

Properties of Luteolin Useful in Autism

• Reduces oxidative stress• Inhibits inflammation• Inhibits mast cell activation• Inhibits microglia activation• Inhibits neurotoxicity• Is weak metal chelator• Increases memory• Prevents autism-like behavior in mice

4/8/2016 Copyright by Dr. TC Theoharides 42

0

10

20

30

40

50

60

70

80

90

100

Histamine Tryptase IL-6 IL-8 TNF-alpha

Per

cen

t in

hib

itio

n

*

** *

*

Inhibition of inflammatory molecules by quercetin from human mast cells

Effect of luteolin on SP-induced human mast cell secretion

15

4/8/2016 Copyright by Dr. TC Theoharides 43

4/8/2016 Copyright by Dr. TC Theoharides 44

4/8/2016 45Copyright by Dr. TC Theoharides

Jang et al. Proc Natl Acad Sci USA, 2008;105:7534-9

Luteolin significantly inhibitedIL-6-induced behavioral deficits in social interactions in mice

16

4/8/2016 46Copyright by Dr. TC Theoharides

4/8/2016 Copyright by Dr. TC Theoharides 48

17

Methoxyluteolin Inhibits Inflammatory Molecule Release from Human Microglia

4/8/2016 Copyright by Dr. TC Theoharides 49

Methoxyluteolin Inhibits IL-33/SP-Induced TNF Secretion and NFB Activation in Mast Cells

4/8/2016 Copyright by Dr. TC Theoharides 51

Mast Cell Triggers

PI3K

AKT

mTORC1

PTENMast cell number

mast cell activation

Mast cell number

Rapamycin

Luteolin

Calcium influx via receptor

Methoxyuteolin inhibits mTOR activation

1-Control 2-Rapamycin 3-Methoxyluteolinteolin

MAST CELL SECRETION

18

4/8/2016 Copyright Dr. T.C. Theoharides 52

A novel, hypoallergenic, anti-oxidant, flavonoid lotion for dry, irritated or sensitive skin

Hydrates-Nourishes–Soothes-Rejuvenates-RepairsLet Nature Calm Your SkinTM

Net weight 2 oz (56.7 gm)

Ingredients: Water, organic aloe barbadensis leaf juice, olea europea (olive) fruit oil, glycerin, organic helianthus annuus (sunflower) seed oil, steareth-21, stereath-2, cetyl

alcohol, stearyl alcohol, glyceryl stearate, lanolin, tetramethoxyflavone, sodium benzoate, quaternium-15, disodium EDTA, magnesium chloride, honey, sodium chloride, potassium

chloride, tetrahexyldecyl ascorbate, origanum vulgare oil, disodium phosphate

Made for Algonot, LLC, 5111 Ocean Bvd-Suite J Sarasota, FL 34242, USA-Toll Free 1-800-254-6668

www.gentlederm.com

GentleDermTM

A B C D

Photos of lesional skin areas. Areas were photographed before (upper panels) and after (lower panels) using GentleDerm® twice daily for two weeks. (A,B) eczema: (A) face of a 51 year-old female patient with

mast cell activation syndrome and (B) abdomen of 43 year-old female patient with mast cell activation syndrome;(C,D) psoriasis: (C) leg of a 47 year-old male patient with indolent systemic mastocytosis and (D) hand of

39 year-old female patient with mast cell activation syndrome.

Mast Cell

Microglia

Inflammatory

mediators

Neurons

Neuronal damage and impaired connectivity

H

No trigger Triggers +Atopy + CRH +Neurotensin + mTOR activation

Triggers +Atopy

Triggers

INSCREASED RISK OR AUTISMTriggers +Atopy + CRH+Neurotensin

Lut & Methlut

Treatment Approaches• Reduce anxiety/pressure

• Limit sensory overload

• Start speech, music and work support

• Correct vitamin deficiencies

• Supplement methyl donors (glutathione, SAMe, NAC)

• Eliminate food intolerances

• Reduce allergies

• Add anti-oxidants (Omega-3, sulforaphane)

• Address inflammation (luteolin, methoxyluteolin)

4/8/2016 Copyright by Dr. TC Theoharides 54

19

4/8/2016 Copyright by Dr. TC Theoharides 55

Research Funding:

• DK62861 • AR47652 • NS071361 • NS55681• AR60951• NS66205

• Autism Research Collaborative

• National Autism Association

• Safe Minds• Autism Research

Institute• Jane B Johnson Fnd.

4/8/2016 55

drtheoharides@gmail.comwww.mastcellmaster.comwww.autismfreebrain.org

www.brain-gate.org